Publications
- Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients2024 | First Faculty of Medicine, Second Faculty of Medicine
- Effect of SARS-CoV-2 infection on anti-HLA antibodies and de novo donor specific antibodies incidence in lung transplant recipients2023 | First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model2023 | First Faculty of Medicine, Second Faculty of Medicine
- Demonstration of the Rationale for Therapeutic Drug Monitoring of Isavuconazole: A Case Report with a Lung Transplant Recipient2023 | First Faculty of Medicine, Second Faculty of Medicine
- Impaired Humoral Response to Third Dose of BNT162b2 mRNA COVID-19 Vaccine Despite Detectable Spike Protein-specific T cells in Lung Transplant Recipients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients2022 | First Faculty of Medicine, Second Faculty of Medicine
- Immunogenicity of BNT162b2 mRNA COVID-19 vaccine and SARS-CoV-2 infection in lung transplant recipients2021 | First Faculty of Medicine, Second Faculty of Medicine
- Elimination and penetration of amikacin into urine in patients with decreased glomerular filtration rate2024 | First Faculty of Medicine, Central Library of Charles University
- Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications2023 | First Faculty of Medicine
- The frequency of, and predisposing risk factors for, ciprofloxacin-induced neuro-psychiatric adverse drug reactions2023 | First Faculty of Medicine
Loading network view...